Infectious Diseases News and Research

RSS

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.

12 Jun 2020

Does COVID-19 injure the placenta of pregnant women?

News-Medical speaks to Dr. Jeffery Goldstein about whether COVID-19 is damaging the placentas of pregnant women and what women can do to protect themselves.

12 Jun 2020

Drug-like molecules offer a promising treatment for COVID-19

A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein - providing a promising path for new COVID-19 therapeutics.

12 Jun 2020

Study initiates hydroxychloroquine clinical trial to prevent COVID-19 in healthy people

Rush University Medical Center has opened enrollment for a new clinical trial investigating whether the drug hydroxychloroquine is better than a placebo in preventing COVID-19 infection in healthy people working in health care settings.

12 Jun 2020

Researchers are developing statistical tools to analyze the spread and evolution of coronavirus

For as much as the scientific community has learned about the novel coronavirus, SARS-CoV-2, since it emerged in China last year, many key aspects of the pandemic remain a mystery.

12 Jun 2020

Ashion Analytics is now part of NCI's MATCH cancer clinical trials

Ashion Analytics, a clinical laboratory of the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is now part of the National Cancer Institute's MATCH program, which provides patients who have rare or difficult-to-treat cancers with access to unique clinical trials nationwide that might give them the best therapeutic treatments and outcomes.

12 Jun 2020

UNC scientists develop new kind of antibody test for COVID-19

As the COVID-19 pandemic continues with many thousands of new infections reported each day, there is a need for widely applicable surveillance testing to gain a better understanding of infection rates, especially the number of infections in people with mild or no symptoms, who can still be carriers.

11 Jun 2020

COVID-19 poses a global threat to the entire nervous system

A new review of neurological symptoms of COVID-19 patients in current scientific literature reveals the disease poses a global threat to the entire nervous system, reports a Northwestern Medicine study published this week in Annals of Neurology.

11 Jun 2020

Co-existing non-communicable diseases linked to higher risk of illness and death from COVID-19

The interaction of COVID-19 with co-existing non-communicable diseases (NCDs) is a perfect storm, particularly for communities of poverty, according to a new opinion piece published by Columbia Mailman School of Public Health researchers in the journal British Medical Journal.

11 Jun 2020

Article calls for international governance system to oversee access to Covid-19 vaccines, treatments

Human challenge trials to test the efficacy of vaccine candidates against SARS? CoV? 2, the novel coronavirus behind COVID? 19, could save considerable time and many lives.

11 Jun 2020

A lead compound can significantly reduce or eliminate toxoplasmosis and malaria

Toxoplasma gondii infection is one of the most frequent parasitic infections of humans. This parasite is present in the brain of an estimated two billion people--about 40 percent of all humans on earth. It is endemic throughout the world, causing water and food-borne epidemics that result in toxoplasmosis.

10 Jun 2020

EHR data could help avoid pre-term deliveries for pregnant COVID-19 patients

Using electronic health record data to simulate drug trials for pregnant patients could one day offer a solution to the current practice of delivering babies pre-term if an expectant mother contracts COVID-19, according to a position paper published in Nature Medicine.

10 Jun 2020

Baboon could prove to be a relevant model to test Alzheimer's disease interventions

Scientists at Texas Biomedical Research Institute's Southwest National Primate Research Center recently published findings indicating the baboon could prove to be a relevant model to test therapeutics and interventions for neurodegenerative diseases, such as early stage Alzheimer's and related dementias.

10 Jun 2020

Mozart listening associated with reduced seizure frequency in patients with epilepsy

A new clinical research study by Dr. Marjan Rafiee and Dr. Taufik Valiante of the Krembil Brain Institute at Toronto Western Hospital, part of University Health Network, has found that a Mozart composition may reduce seizure frequency in patients with epilepsy.

10 Jun 2020

Blood type plays role in SARS-CoV-2 infection

A new meta-analysis from Iran, available on the medRxiv preprint server, showed that the blood group A could be considered a partial risk factor for infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whereas the blood group O may act as a protective factor; conversely, no significant associations were observed between specific blood groups and coronavirus disease (COVID-19) mortality.

10 Jun 2020

Infectious Diseases News and Research

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

Does COVID-19 injure the placenta of pregnant women?

Drug-like molecules offer a promising treatment for COVID-19

Study initiates hydroxychloroquine clinical trial to prevent COVID-19 in healthy people

Researchers are developing statistical tools to analyze the spread and evolution of coronavirus

Ashion Analytics is now part of NCI's MATCH cancer clinical trials

UNC scientists develop new kind of antibody test for COVID-19

COVID-19 poses a global threat to the entire nervous system

Co-existing non-communicable diseases linked to higher risk of illness and death from COVID-19

Article calls for international governance system to oversee access to Covid-19 vaccines, treatments

A lead compound can significantly reduce or eliminate toxoplasmosis and malaria

EHR data could help avoid pre-term deliveries for pregnant COVID-19 patients

Baboon could prove to be a relevant model to test Alzheimer's disease interventions

Mozart listening associated with reduced seizure frequency in patients with epilepsy

Blood type plays role in SARS-CoV-2 infection

Expanding flu vaccine coverage could reduce inappropriate antibiotic prescribing

Internet searches can help track the spread of COVID-19, says UofL researcher

Immuno-oncology may accelerate the development of treatments for COVID-19

The 1918 flu pandemic can help mitigate the spread of COVID-19

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News